Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage
Author:
Funder
Union University
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference31 articles.
1. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis;DiSipio;Lancet Oncol.,2013
2. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors;Knobf;Breast Cancer Oncol.,2006
3. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer;Coley;Cancer Treat. Rev.,2008
4. Designing a broad-spectrum integrative approach for cancer prevention and treatment;Block;Semin. Cancer Biol.,2015
5. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling;Wilhelm;Mol. Cancer Ther.,2008
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bis(thiosemicarbazide)gallium(III) Complexes as Potent Anticancer Agents by ROS Induction and Mitochondrial Pathway Activation;Applied Organometallic Chemistry;2024-08-26
2. Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways;Current Medicinal Chemistry;2024-08
3. Resveratrol in the Treatment of Gynecological Cancer: Mechanisms and Therapeutic Potential;Current Medicinal Chemistry;2024-05-03
4. Structural characterization of the polysaccharide from the black crystal region of Inonotus obliquus and its effect on AsPC-1 and SW1990 pancreatic cancer cell apoptosis;International Journal of Biological Macromolecules;2024-05
5. Development of novel pyrimidine nucleoside analogs as potential anticancer agents: Synthesis, characterization, and In-vitro evaluation against pancreatic cancer;European Journal of Pharmaceutical Sciences;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3